These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10321955)

  • 1. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation.
    Eckels DD; Tabatabail N; Bian TH; Wang H; Muheisen SS; Rice CM; Yoshizawa K; Gill J
    Hum Immunol; 1999 Mar; 60(3):187-99. PubMed ID: 10321955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein.
    Tabatabai NM; Bian TH; Rice CM; Yoshizawa ; Gill J; Eckels DD
    Hum Immunol; 1999 Feb; 60(2):105-15. PubMed ID: 10027778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell antigenic determinants within hepatitis C virus nonstructural protein 3 and cytokine production profiles in hepatitis C.
    Pan CH; Yang PM; Hwang LH; Kao SF; Chen PJ; Chiang BL; Chen DS
    J Viral Hepat; 2002 Jul; 9(4):258-64. PubMed ID: 12081602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.
    Hempel G; Galle PR; Löhr HF
    J Med Virol; 2001 Jul; 64(3):340-9. PubMed ID: 11424124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
    Cusick MF; Yang M; Gill JC; Eckels DD
    Hum Immunol; 2011 May; 72(5):379-85. PubMed ID: 21377503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.
    Tsai SL; Chen PJ; Hwang LH; Kao JH; Huang JH; Chang TH; Chen DS
    J Hepatol; 1994 Sep; 21(3):403-11. PubMed ID: 7530738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity.
    Tsai SL; Liaw YF; Chen MH; Huang CY; Kuo GC
    Hepatology; 1997 Feb; 25(2):449-58. PubMed ID: 9021963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
    Rollier C; Depla E; Drexhage JA; Verschoor EJ; Verstrepen BE; Fatmi A; Brinster C; Fournillier A; Whelan JA; Whelan M; Jacobs D; Maertens G; Inchauspé G; Heeney JL
    J Virol; 2004 Jan; 78(1):187-96. PubMed ID: 14671100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting.
    Rollier C; Verschoor EJ; Paranhos-Baccala G; Drexhage JA; Verstrepen BE; Berland JL; Himoudi N; Barnfield C; Liljestrom P; Lasarte JJ; Ruiz J; Inchauspe G; Heeney JL
    J Infect Dis; 2005 Sep; 192(5):920-9. PubMed ID: 16088843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy.
    Zhang ZX; Milich DR; Peterson DL; Birkett A; Schvarcz R; Weiland O; Sällberg M
    J Infect Dis; 1997 Jun; 175(6):1294-301. PubMed ID: 9180166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.
    Brady MT; MacDonald AJ; Rowan AG; Mills KH
    Eur J Immunol; 2003 Dec; 33(12):3448-57. PubMed ID: 14635055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro.
    Kita H; Moriyama T; Kaneko T; Hiroishi K; Harase I; Miura H; Nakamura I; Inamori H; Kodama T; Ohnishi S
    J Med Virol; 1995 Apr; 45(4):386-91. PubMed ID: 7545209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.